Oncology & Cancer

Cell environment influences type of liver tumor

Liver cancer is the second leading cause of cancer death worldwide. Two forms of primary liver cancer cover the majority of cases: About 10 to 20 percent of those affected develop a bile duct carcinoma within the liver (intrahepatic ...

Oncology & Cancer

Researchers discover new anti-cancer protein

An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from ...

Oncology & Cancer

Researchers identify UHRF1 as oncogene driving liver cancer

Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data ...

Medications

DAAs cut deaths in those treated for HCV-related liver cancer

(HealthDay)—Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the ...

Oncology & Cancer

TGen review links gene with the most common liver cancer

Hepatocellular carcinoma (HCC) is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., ...

page 1 from 11